Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference
Sutro Biopharma, Inc. (STRO)
Last sutro biopharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced its participation at the 16th Annual World ADC Conference, taking place in San Diego, November 3-6, 2025. “We look forward to presenting new preclinical data at this year’s World ADC conference that underscore the breadth of innovation emerging from Sutro’s platform and the meaningful progress we’re making toward advancing the next-generation of ADCs,” said Hans-Peter Gerber, Sutro’s Chief Scientific Officer. “Among the highlights, we’re excited to share results demonstrating how our dual-payload ADCs, including immunostimulatory ADCs, can potentially redefine treatment paradigms by enhancing therapeutic index and addressing tumor resistance—two of the biggest challenges in oncology today. Together with our unique cell-free platform, these advances re
Show less
Read more
Impact Snapshot
Event Time:
STRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STRO alerts
High impacting Sutro Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
STRO
News
- Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $23.00 price target on the stock.MarketBeat
- Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.MarketBeat
- Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash Wisely [Yahoo! Finance]Yahoo! Finance
- Ipsen outlays $1bn for China-based Simcere's preclinical ADC [Yahoo! Finance]Yahoo! Finance
STRO
Earnings
- 5/8/25 - Miss
STRO
Sec Filings
- 12/29/25 - Form 4
- 12/29/25 - Form 4
- 12/29/25 - Form 4
- STRO's page on the SEC website